Diabetes Kongress 2019
zur Liste
Dr. Dr. Haifa Maalmi
Haifa Maalmi, PhD, PhDResearch Interests Proteomic biomarkers; Diabetes complications; Neuropathy; Precision diabetology; Epidemiology Research ExperienceSince 2018.09 Senior Epidemiologist DDZ, Duesseldorf2015-02 - 2018-01 Doctoral researcher in epidemiology; University of Heidelberg2010-09 - 2014-07 Doctoral researcher in Biology; University of Tunis El Manar Education 2015-02 - 2018-01 PhD in Epidemiology; University of Heidelberg, Germany 2010-09 - 2014-07 PhD in Biology; University of Tunis El Manar, Tunisia 2008-09 - 2010-07 MSc in Biology; University of Tunis El Manar, TunisiaInternational Research Stays 3 months contract Weill Cornell Medicine, Doha5 months scholarship University of Nantes 3 months scholarship DKFZ, Heidelberg FundingDDG, DZD and EFSD/Novo Nordisk FoundationSelected publicationsMaalmi H, Strom A, Hauck S, Zaharia OP, Strassburger K, Bönhof G, Rathmann W, Trenkamp S, Burkart Julia S, Ziegler D, Roden M, Herder C. High Throughput Proteomics Identifies Neurofilament Light Chain (NFL) as a Novel Blood Biomarker for Detection of Diabetic Sensorimotor Polyneuropathy. Diabetologia, 2022.Maalmi H, Herder C, Bönhof GJ, Strassburger K, Zaharia OP, Rathmann W, Burkart V, Szendroedi J, Roden M, Ziegler D. Differences in the prevalence of erectile dysfunction between novel subgroups of recent-onset diabetes. Diabetologia. 2022; 65(552-562).Maalmi H, Herder C, Huth C, Rathmann W, Bönhof GJ, Heier M, Koenig W, Roden M, Peters A, Ziegler D, Thorand B. Effect of obesity on the associations of 25-hydroxyvitamin D with prevalent and incident distal sensorimotor polyneuropathy: population-based KORA F4/FF4 study. Int J Obes. 2022.Maalmi H, Wouters K, Savelberg H, van der Velde J, Reulen JPH, Mess W, Schalkwijk CG, Stehouwer CDA, Roden M, Ziegler D, Herder C, Schaper NC. Associations of cells from both innate and adaptive immunity with lower nerve conduction velocity: the Maastricht Study. BMJ Open Diabetes Res Care. 2021; 9.Maalmi H, Herder C, Strassburger K, Urner S, Jandeleit-Dahm K, Zaharia OP, Karusheva Y, Bongaerts BWC, Rathmann W, Burkart V, Szendroedi J, Roden M. Biomarkers of Inflammation and Glomerular Filtration Rate in Individuals with Recent-Onset Type 1 and Type 2 Diabetes. J Clin Endocrinol Metab. 2020; 105.Herder C*, Maalmi H*, Strassburger K, Zaharia OP, Ratter JM, Karusheva Y, Elhadad MA, Bódis K, Bongaerts BWC, Rathmann W, Trenkamp S, Waldenberger M, Burkart V, Szendroedi J, Roden M. Differences in Biomarkers of Inflammation Between Novel Subgroups of Recent-Onset Diabetes. Diabetes. 2021; 70(1198-1208).Herder C*, Maalmi H*, Saatmann N, Zaharia OP, Strassburger K, Burkart V, Norman K, Roden M. Determinants of Skeletal Muscle Mass and Differences Between Novel Subgroups in Recent-Onset Diabetes (under review)
Deutsches Diabetes-Zentrum (DDZ) Germany
  • Vortrag Inverse associations between serum afamin concentrations and inflammatory biomarkers in an older adult population: Results from KORA F4 study Speaker
    Datum: 30.05.2019 , Zeit: 14:40 | Thema: Typ-2-Diabetes
    Details
  • Vortrag Higher circulating levels of omentin are associated with a higher risk of primary cardiovascular events in patients with type 2 diabetes: Results from the ESTHER study Autor:in
    Datum: 31.05.2019 , Zeit: 10:55 | Thema: 03. Grundlagenforschung Typ-1-Diabetes/ Betazelle/ Typ-1-Diabetes/ Adipositas/ Fettgewebe
    Details
  • Vortrag Higher circulating levels of omentin are associated with a higher risk of primary cardiovascular events in patients with type 2 diabetes: Results from the ESTHER study Autor:in
    Datum: 31.05.2019 , Zeit: 10:55 | Thema: 03. Grundlagenforschung Typ-1-Diabetes/ Betazelle/ Typ-1-Diabetes/ Adipositas/ Fettgewebe
    Details